Literature DB >> 22902085

Evaluation and management of opioid dependence in pregnancy.

Eliza M Park1, Samantha Meltzer-Brody, Joji Suzuki.   

Abstract

BACKGROUND: Opioid use disorders are a growing public health problem in the United States. Most women who are opioid-dependent are of childbearing age, and management of opioid dependence during pregnancy poses unique challenges. Assessment includes evaluation for addiction, withdrawal syndromes, and comorbid psychiatric diagnoses. Consultation-liaison (C-L) psychiatrists may also be involved in acute pain management, perinatal medication management, buprenorphine induction, and stabilization. For the past four decades, the standard of care has included methadone maintenance, but the increasing use of buprenorphine creates new treatment issues and opportunities.
OBJECTIVE: To educate C-L psychiatrists in emergency and obstetrical settings about the appropriate approach toward the evaluation and basic management of women with opioid dependence in pregnancy.
METHOD: The authors reviewed the consensus literature and all new treatment options on opioid dependence during pregnancy. DISCUSSION: In this review, the authors summarize known and emerging management strategies for opioid dependence in pregnancy pertinent to C-L psychiatrists.
Copyright © 2012 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22902085      PMCID: PMC5298932          DOI: 10.1016/j.psym.2012.04.003

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  52 in total

1.  The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women.

Authors:  H E Jones; N Haug; K Silverman; M Stitzer; D Svikis
Journal:  Drug Alcohol Depend       Date:  2001-02-01       Impact factor: 4.492

Review 2.  Pharmacotherapy for pregnant women with addictions.

Authors:  William F Rayburn; Michael P Bogenschutz
Journal:  Am J Obstet Gynecol       Date:  2004-12       Impact factor: 8.661

3.  Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy.

Authors:  Marjorie Meyer; Gretchen Paranya; Ananda Keefer Norris; Diantha Howard
Journal:  Eur J Pain       Date:  2010-05-04       Impact factor: 3.931

4.  Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.

Authors:  Hendree E Jones; Rolley E Johnson; Donald R Jasinski; Kevin E O'Grady; Christian A Chisholm; Robin E Choo; Michael Crocetti; Robert Dudas; Cheryl Harrow; Marilyn A Huestis; Lauren M Jansson; Michael Lantz; Barry M Lester; Lorraine Milio
Journal:  Drug Alcohol Depend       Date:  2005-07       Impact factor: 4.492

5.  Menstrual cycle length during methadone maintenance.

Authors:  John Schmittner; Jennifer R Schroeder; David H Epstein; Kenzie L Preston
Journal:  Addiction       Date:  2005-06       Impact factor: 6.526

6.  Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.

Authors:  Tomás Binder; Blanka Vavrinková
Journal:  Neuro Endocrinol Lett       Date:  2008-02       Impact factor: 0.765

7.  Is opiate detoxification unsafe in pregnancy?

Authors:  Jason Luty; Vasilis Nikolaou; Jenny Bearn
Journal:  J Subst Abuse Treat       Date:  2003-06

8.  Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.

Authors:  Johan Kakko; Markus Heilig; Ihsan Sarman
Journal:  Drug Alcohol Depend       Date:  2008-03-19       Impact factor: 4.492

9.  Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: health, developmental, and social implications.

Authors:  G S Wilson; M M Desmond; R B Wait
Journal:  J Pediatr       Date:  1981-05       Impact factor: 4.406

Review 10.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14
View more
  5 in total

1.  Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment.

Authors:  Brandi Jancaitis; Sydney Kelpin; Saba Masho; James May; Nancy A Haug; Dace Svikis
Journal:  Women Health       Date:  2019-05-08

Review 2.  The brain-placental axis: Therapeutic and pharmacological relevancy to pregnancy.

Authors:  Susanta K Behura; Pramod Dhakal; Andrew M Kelleher; Ahmed Balboula; Amanda Patterson; Thomas E Spencer
Journal:  Pharmacol Res       Date:  2019-10-07       Impact factor: 7.658

Review 3.  Buprenorphine use in pregnant opioid users: a critical review.

Authors:  Michael Soyka
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

Review 4.  Prenatal opioid exposure and vulnerability to future substance use disorders in offspring.

Authors:  Yaa Abu; Sabita Roy
Journal:  Exp Neurol       Date:  2021-01-29       Impact factor: 5.330

5.  Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States.

Authors:  Valerie E Whiteman; Jason L Salemi; Mulubrhan F Mogos; Mary Ashley Cain; Muktar H Aliyu; Hamisu M Salihu
Journal:  J Pregnancy       Date:  2014-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.